Global Cancer Informatics Market Research Report: Forecast (2021-2026)
By Product (Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support System (CDSS), Drug Discovery and Development Informatics (DDDI)), By Ap...plication (Medical Application, Surgical Application, Radiation Application), By Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other), By End-Users (Life Science industry, Academic Institutes and Research Centers, Pharmaceutical Companies, Contract Research Organizations (CROs), Others (Hospitals and Other Care Facilities)), By Region (North America, South America, Europe, Asia-Pacific, Middle East and Africa), By Country (US, Canada, Mexico, Brazil, UK, Italy, Germany, France, Russia, Spain, Saudi-Arabia, South-Africa, China, India, Japan, South-Korea, Australia), By Competitors (Elekta ab, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Hologic Inc., F.Hoffmann-La Roche Ltd., McKesson Corporation) Read more
- Healthcare
- Apr 2021
- 203
- PDF, Excel, PPT
Market Overview
Cancer Informatics is a comprehensive information solution that explores the crucial technologies, informatics trends of applying computational biology to cancer research and care. In Cancer Informatics, computer & information science and healthcare interconnect to acquire, store and use information regarding cancer thoroughly & efficiently.
According to the MarkNtel Advisors' research report, "Global Cancer Informatics Market Analysis, 2021," the market is likely to grow at a CAGR of around 7.5% during 2021-26. The growth of the cancer informatics market attributes to the rising prevalence of cancer, surging costs of cancer treatment, and mounting focus on reducing medical errors & readmission rates. However, the high costs involved while installing these solutions are amongst the most prominent challenges for the market.
Report Coverage | Details |
---|---|
Study Period | Historical Data: 2016-19 |
Base Year: 2020 | |
Forecast Period: 2021-26 | |
CAGR | 7.5% |
Regions Covered | North America: USA, Canada |
Europe: Germany, The UK, France, Spain, Italy and Others | |
Asia-Pacific: China, India, Japan, South Korea, Australia and Others | |
South America: Brazil, Mexico | |
Middle East & Africa: Saudi Arabia, South Africa, Rest of the Middle East & Africa | |
Key Companies Profiled | Elekta ab, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Hologic Inc., F.Hoffmann-La Roche Ltd., McKesson Corporation |
Unit Denominations | USD Million/Billion |
Impact of COVID-19
The outbreak of the COVID-19 pandemic has adversely affected cancer patients as most cancer patients are of older age and immunosuppressed. Additionally, lockdown imposition, social distancing measures, and the need for isolation in the pandemic-frenzied world have been convenient factors for delayed follow-up and postponement in routine screening procedures. However, the market players are focused on developing cloud and AI-based technologies to control the impact of the COVID-19 pandemic on the cancer informatics market.
Medical Application Accounted for the Largest Market Share
Based on the Application, the market classifies into medical, surgical, and radiation applications. The Medical application acquired the largest share in the global cancer informatics market in the previous year. The growth attributes to the rising usage of immunotherapy & chemotherapy and snowballing cancer informatics to manage & analyze patient information and predict treatment, thereby improving survival rates and presenting growth opportunities for the market, reveals MarkNtel Advisors in their research report, "Global Cancer Informatics Market Analysis, 2021."
Electronic Health Records (EHRs) Dominated the Market
Electronic Health Records accounted for the largest market share in the global cancer informatics market in the previous few years. Electronic Health Records are electronic versions of a patient’s medical history consisting of their relevant clinical data under a particular provider. With the help of EHR, the medical record-keeping procedure becomes more centralized and easily accessible.
Additionally, EHR offers numerous other benefits, such as enhanced quality of patient care, reduced health care costs, and an easy transfer of a patient’s information among providers, thereby contributing to the growth of the cancer informatics market in the forecast period.
Regional Landscape
North America Grabbed the Largest Market Share
Region-wise, North America held the largest market share in the global cancer informatics market in the previous year due to the rising adoption of advanced technologies in the healthcare sector and mounting investments by pharmaceutical industries. The United States dominates the North American region due to the surging number of cancer patients and massive investments in cancer R&D.
Market Driver
Emerging Technological Advancements Drives the Market Growth
Soaring adoption of advanced technologies in healthcare leads to enhanced diagnostic methods for better treatment and reduced readmission rates. Further, the integrated diagnostic approach helps accurately formulate the way for precision medicine, which would also help provide appropriate treatments and reduce errors in the clinical workflow.
Competitive Landscape
According to MarkNtel Advisors, the major leading players in the global Cancer Informatics market are Elekta ab, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Hologic Inc., F.Hoffmann-La Roche Ltd., McKesson Corporation, etc.
Key Questions Answered in the Market Research Report:
- What are the overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of the Global Cancer Informatics Market?
- What are the region-wise industry size, growth drivers, and challenges?
- What are the key innovations, opportunities, current & future trends, and regulations in the Global Cancer Informatics Market?
- Who are the key competitors, their key strengths & weaknesses, and how do they perform in Global Cancer Informatics Market based on a competitive benchmarking matrix?
- What are the key results derived from the market surveys conducted during the Global Cancer Informatics Market study?
Market Outlook, Segmentation and Statistics
- Impact of COVID-19 on Global Cancer Informatics Market
- Market Size & Analysis
- By Revenue
- Market Share & Analysis
- By Product
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics (DDDI)
- By Application
- Medical Application
- Surgical Application
- Radiation Application
- By Cancer Type
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Other
- By End-Users
- Life Science industry
- Academic Institutes and Research Centres
- Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Others (Hospitals and Other Care Facilities)
- By Region
- North America
- Latin America
- Europe
- Middle East & Africa
- Asia-Pacific
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- Competitive Metrix
- By Product
- Global Cancer Informatics Market Hotspots & Opportunities
- Global Cancer Informatics Market Regulations & Policy
- Key Strategic Imperatives for Success and Growth
- Global Competition Outlook
- Competition Matrix
- Company Profile
Frequently Asked Questions
- Introduction
- Product Definition
- Research Process
- Market Segmentation
- Assumptions
- Preface
- Executive Summary
- Impact of COVID-19 on Global Cancer Informatics Market
- Global Cancer Informatics Market Dynamics
- Growth Drivers
- Challenges
- Impact Analysis
- Global Cancer Informatics Market Policies and Product Standards
- Global Cancer Informatics Market Trends & Insights
- Global Cancer Informatics Market Hotspot & Opportunities
- Global Cancer Informatics Market Key Strategic Imperatives for Success & Growth
- Global Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Product
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics (DDDI)
- By Application
- Medical Application
- Surgical Application
- Radiation Application
- By Cancer Type
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Other
- By End-Users
- Life Science industry
- Academic Institutes and Research Centers
- Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Others (Hospitals and Other Care Facilities)
- By Region
- North America
- Latin America
- Europe
- Middle East & Africa
- Asia-Pacific
- By Company
- Competition Characteristics
- Market Share & Analysis
- Competitive Matrix
- By Product
- Market Size & Analysis
- North America Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- By Country
- The US
- Canada
- The US Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Canada Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Market Size & Analysis
- Latin America Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- By Country
- Brazil
- Mexico
- Others
- Brazil Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Mexico Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Market Size & Analysis
- Europe Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- By Country
- The UK
- Italy
- Germany
- France
- Spain
- Russia
- The UK Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Italy Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Germany Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- France Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Spain Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Russia Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Market Size & Analysis
- Middle East & Africa Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- By Country
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Saudi Arabia Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- South Africa Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Market Size & Analysis
- Asia-Pacific Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- By Country
- China
- Japan
- India
- South Korea
- Australia
- Others
- China Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Japan Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- India Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- South Korea Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Australia Cancer Informatics Market Outlook, 2016-2026F
- Market Size & Analysis
- Revenues
- Market Share & Analysis
- By Product
- By Application
- By Cancer Type
- By End-Users
- Market Size & Analysis
- Competition Outlook
- Competition Matrix
- Product/ Solution Portfolio
- Target Markets
- Target End Users
- Research & Development
- Strategic Alliances
- Strategic Initiatives
- Competition Matrix
- Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
- Elekta ab
- Varian Medical Systems
- Accuray Incorporated
- Cerner Corporation
- RaySearch Laboratories
- Flatiron
- Oncology Analytics, Inc
- Hologic Inc.
- F.Hoffmann-La Roche Ltd.
- McKesson Corporation
- Disclaimer